Nektar Therapeutics (NASDAQ:NKTR)
| 0.5852 Delayed Data As of Jun 09 |  -0.0173 / -2.87%Today’s Change | 0.58 Today|||52-Week Range 5.18 | -74.11% Year-to-Date |
Latest NKTR News | Press Releases
| Why Is Nektar (NKTR) Down 19.7% Since Last Earnings Report? Jun 08 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.60 |
| Today’s open | 0.60 |
| Day’s range | 0.59 - 0.61 |
| Volume | 70,099 |
| Average volume (3 months) | 4,357,707 |
| Market cap | $117.2M |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | +31.15% |
| Earnings growth (this year) | +31.22% |
| Earnings growth (next 5 years) | +14.89% |
| Revenue growth (last year) | -9.67% |
| P/E ratio | NM |
| Price/Sales | 4.59 |
| Price/Book | 0.32 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SEELSeelos Therapeutics ... | -0.00 | -0.14% |
| TCRTAlaunos Therapeutics... | +0.00 | +1.00% |
| ---- | ||
| ---- |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $92.1M |
| Annual profit (last year) | -$368.2M |
| Net profit margin | -399.98% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
